Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thilo Sprenger

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Annals of Surgical Oncology|February 25, 2011
Thymidylate synthase as a prognostic biomarker for locally advanced rectal cancer after multimodal treatmentLena-Christin Conradi, Annalen Bleckmann, Markus Schirmer, et al.
Cancer|June 28, 2012
Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survivalThilo Sprenger, Lena-Christin Conradi, Tim Beissbarth, et al.
International Journal of Radiation Oncology, Biology, Physics|November 12, 2013
Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 studyEmmanouil Fokas, Lena Conradi, Christian Weiss, et al.
Oncotarget|April 28, 2015
HER-2 and HER-3 expression in liver metastases of patients with colorectal cancerHanna Styczen, Iris Nagelmeier, Tim Beissbarth, et al.
The American Journal of Surgical Pathology|January 4, 2013
Frequency of HER-2 positivity in rectal cancer and prognosisLena-Christin Conradi, Hanna Styczen, Thilo Sprenger, et al.
Case Reports in Oncology|January 30, 2014
Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse EventHenriette Quack, Luise Erpenbeck, Hendrik A Wolff, et al.
The American Journal of Surgical Pathology|January 19, 2012
Optimal lymph node harvest in rectal cancer (UICC stages II and III) after preoperative 5-FU-based radiochemotherapy. Acetone compression is a new and highly efficient methodAnastasia Gehoff, Oliver Basten, Thilo Sprenger, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Annals of Surgical Oncology|February 25, 2011
Thymidylate synthase as a prognostic biomarker for locally advanced rectal cancer after multimodal treatmentLena-Christin Conradi, Annalen Bleckmann, Markus Schirmer, et al.
Cancer|June 28, 2012
Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survivalThilo Sprenger, Lena-Christin Conradi, Tim Beissbarth, et al.
International Journal of Radiation Oncology, Biology, Physics|November 12, 2013
Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 studyEmmanouil Fokas, Lena Conradi, Christian Weiss, et al.
Oncotarget|April 28, 2015
HER-2 and HER-3 expression in liver metastases of patients with colorectal cancerHanna Styczen, Iris Nagelmeier, Tim Beissbarth, et al.
The American Journal of Surgical Pathology|January 4, 2013
Frequency of HER-2 positivity in rectal cancer and prognosisLena-Christin Conradi, Hanna Styczen, Thilo Sprenger, et al.
Case Reports in Oncology|January 30, 2014
Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse EventHenriette Quack, Luise Erpenbeck, Hendrik A Wolff, et al.
The American Journal of Surgical Pathology|January 19, 2012
Optimal lymph node harvest in rectal cancer (UICC stages II and III) after preoperative 5-FU-based radiochemotherapy. Acetone compression is a new and highly efficient methodAnastasia Gehoff, Oliver Basten, Thilo Sprenger, et al.
Pageof 3